Sam Chun Dang Pharm Co Stock

Sam Chun Dang Pharm Co P/S 2024

Sam Chun Dang Pharm Co P/S

7.43

Ticker

000250.KQ

ISIN

KR7000250001

As of Nov 15, 2024, Sam Chun Dang Pharm Co's P/S ratio stood at 7.43, a 36.83% change from the 5.43 P/S ratio recorded in the previous year.

The Sam Chun Dang Pharm Co P/S history

Sam Chun Dang Pharm Co Aktienanalyse

What does Sam Chun Dang Pharm Co do?

Sam Chun Dang Pharm Co Ltd is a pharmaceutical company specializing in Korean herbal medicine. It was founded in 1947 and is headquartered in Seoul, South Korea. The company has undergone a profound transformation in recent decades to meet the growing demands of the healthcare industry. Sam Chun Dang believes that natural remedies can play an important role in promoting health and well-being. Therefore, the company has focused on manufacturing medicines from natural herbs and plants. Since its inception, the company has aimed for better healthcare and improved quality of life for its customers. In recent years, Sam Chun Dang has become the market leader in the production of herbal medicine in Korea. It produces a variety of medicines, including products for treating traditional Korean ailments such as fatigue, loss of appetite, and colds. The company maintains several research centers and production facilities to ensure the preservation of its products' high quality. These centers are equipped with state-of-the-art equipment and have carefully trained personnel. Sam Chun Dang essentially produces three types of products: herbal medicine, dietary supplements, and health products. Herbal medicine is made from natural ingredients such as ginseng, horsetail, angelica, atractylodes, and many other herbs. Each product undergoes strict control and testing to ensure they meet the highest standards. Sam Chun Dang also produces dietary supplements that possess a wide range of health-promoting properties. These supplements contain vitamins, minerals, proteins, and many other nutrients. They are designed to naturally promote and strengthen the body's health. Additionally, Sam Chun Dang also offers health products such as masks and cleansing products. These products aim to help improve the health and well-being of customers. Sam Chun Dang is an innovative company that is always striving to improve its products and services. Over the years, the company has received several awards recognizing its leadership qualities and innovative products. Overall, Sam Chun Dang Pharm Co Ltd is a leading manufacturer of herbal medicine and dietary supplements with a strong commitment to health. The company has made a name for itself in recent years through its dedication and innovations in manufacturing products from natural ingredients. Sam Chun Dang remains committed to making a positive contribution to the healthcare industry while continuing to provide high-quality and innovative products. Sam Chun Dang Pharm Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Sam Chun Dang Pharm Co's P/S Ratio

Sam Chun Dang Pharm Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Sam Chun Dang Pharm Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Sam Chun Dang Pharm Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Sam Chun Dang Pharm Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Sam Chun Dang Pharm Co stock

What is the price-to-earnings ratio of Sam Chun Dang Pharm Co?

The price-earnings ratio of Sam Chun Dang Pharm Co is currently 7.43.

How has the price-earnings ratio of Sam Chun Dang Pharm Co changed compared to last year?

The price-to-earnings ratio of Sam Chun Dang Pharm Co has increased by 36.83% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Sam Chun Dang Pharm Co high compared to other companies?

Yes, the price-to-earnings ratio of Sam Chun Dang Pharm Co is high compared to other companies.

How does an increase in the price-earnings ratio of Sam Chun Dang Pharm Co affect the company?

An increase in the price-earnings ratio of Sam Chun Dang Pharm Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Sam Chun Dang Pharm Co affect the company?

A decrease in the price-earnings ratio of Sam Chun Dang Pharm Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Sam Chun Dang Pharm Co?

Some factors that influence the price-earnings ratio of Sam Chun Dang Pharm Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Sam Chun Dang Pharm Co pay?

Over the past 12 months, Sam Chun Dang Pharm Co paid a dividend of 50 KRW . This corresponds to a dividend yield of about 0.05 %. For the coming 12 months, Sam Chun Dang Pharm Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Sam Chun Dang Pharm Co?

The current dividend yield of Sam Chun Dang Pharm Co is 0.05 %.

When does Sam Chun Dang Pharm Co pay dividends?

Sam Chun Dang Pharm Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Sam Chun Dang Pharm Co?

Sam Chun Dang Pharm Co paid dividends every year for the past 0 years.

What is the dividend of Sam Chun Dang Pharm Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sam Chun Dang Pharm Co located?

Sam Chun Dang Pharm Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sam Chun Dang Pharm Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sam Chun Dang Pharm Co from 4/6/2020 amounting to 50 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2019.

When did Sam Chun Dang Pharm Co pay the last dividend?

The last dividend was paid out on 4/6/2020.

What was the dividend of Sam Chun Dang Pharm Co in the year 2023?

In the year 2023, Sam Chun Dang Pharm Co distributed 0 KRW as dividends.

In which currency does Sam Chun Dang Pharm Co pay out the dividend?

The dividends of Sam Chun Dang Pharm Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sam Chun Dang Pharm Co

Our stock analysis for Sam Chun Dang Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sam Chun Dang Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.